MODL-03. Establishment of intraventricular Shh inhibition as a therapeutic option for young patients with medulloblastoma

Standard

MODL-03. Establishment of intraventricular Shh inhibition as a therapeutic option for young patients with medulloblastoma. / Kresbach, Catena; Schoof, Melanie; Holst, Lea; Leven, Tara; Yorgan, Timur Alexander; Wrzeszcz, Antonia; Rutkowski, Stefan Josef; Schüller, Ulrich.

In: NEURO-ONCOLOGY, Vol. 24, No. S1, 06.2022, p. i168.

Research output: SCORING: Contribution to journalConference abstract in journalResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{8316f5e402074d778dcecfed366989fb,
title = "MODL-03. Establishment of intraventricular Shh inhibition as a therapeutic option for young patients with medulloblastoma",
author = "Catena Kresbach and Melanie Schoof and Lea Holst and Tara Leven and Yorgan, {Timur Alexander} and Antonia Wrzeszcz and Rutkowski, {Stefan Josef} and Ulrich Sch{\"u}ller",
year = "2022",
month = jun,
doi = "10.1093/neuonc/noac079.626",
language = "English",
volume = "24",
pages = "i168",
journal = "NEURO-ONCOLOGY",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "S1",

}

RIS

TY - JOUR

T1 - MODL-03. Establishment of intraventricular Shh inhibition as a therapeutic option for young patients with medulloblastoma

AU - Kresbach, Catena

AU - Schoof, Melanie

AU - Holst, Lea

AU - Leven, Tara

AU - Yorgan, Timur Alexander

AU - Wrzeszcz, Antonia

AU - Rutkowski, Stefan Josef

AU - Schüller, Ulrich

PY - 2022/6

Y1 - 2022/6

U2 - 10.1093/neuonc/noac079.626

DO - 10.1093/neuonc/noac079.626

M3 - Conference abstract in journal

VL - 24

SP - i168

JO - NEURO-ONCOLOGY

JF - NEURO-ONCOLOGY

SN - 1522-8517

IS - S1

ER -